Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 9/20 | 0.54 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.42 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.42 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PYGM | P11217 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29047907 | 0.89 | CDA (0.55) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL7705298 | 0.81 | CDA (0.54) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL15010376 | 0.78 | CDA (0.54) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL15010708 | 0.76 | CDA (0.52) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL15011257 | 0.76 | CDA (0.52) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL10859054 | 0.75 | CDA (0.52) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| Uridine SCHEMBL29002276 | 0.75 | SLC28A1 (0.73) | SLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL21832053 | 0.74 | CDA (0.50) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL6015184 | 0.72 | CDA (0.66) | CDASLC28A1SLC28A2SLC29A1SLC28A3 | |
| SCHEMBL399314 | 0.72 | CDA (0.66) | CDASLC28A1SLC28A2SLC29A1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117580950-A | Compositions and methods for treating TDP-43 proteinopathies | 梅兹治疗公司 | 2024-02-20 | — | — | CN | disclosed |